Implameq
Manufacturing · Colombia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14 Calle 5 No 30 B2, Cali, Valle del Cau...Website
www.implameq.comRevenue
<$5 MillionIndustry
About Implameq
Implameq Org Chart
Is Implameq your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Implameq is spiking on competitors!
Implameq, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Implameq
Click to see if Implameq had a recent Job posting/layoffs
Product Launch: Get notified when Implameq launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Implameq has new funding data
Check if Implameq has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Implameq recently announced quarterly report
Recommended Actions
Find VP level buyers at Implameq
Find 3 more new buyers
Company Profile Activity
Activity Insights
Implameq is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Implameq is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Implameq.
Implameq Tech Stack
A closer look at the technologies used by Implameq
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Implameq
Implameq is a Colombian company specializing in the distribution of high-quality medical devices and supplies, dedicated to strengthening the healthcare system across the country. They offer a wide range of products including external fixation, spinal implants, arthroscopy, joint replacements, and pediatric osteosynthesis. With a commitment to exce... Read More